Future of cancer research, advocacy, marijuana debate, survivorship issues, providing hope, and giving thanks.
Spring 2006
A closer look at bioidentical hormones and why one pharmaceutical company wants the FDA to keep a closer eye on them.
A cautious approach to supplements and a discussion with your physician while taking them during treatment is a must.
From mastectomy to reconstruction and beyond.
What patients need to know about the new prescription drug plan.
Advertisement
Advertisement
Trending on CURE
1
HR+/HER2- Metastatic Breast Cancer Progression Improved With Sac-TMT
2
Kisqali Plus Aromatase Inhibitor Shows Long-Term Benefit in Early Breast Cancer
3
Presurgical Enhertu Combo Elicits Response Benefit in HER2+ Early Breast Cancer
4
Tiragolumab Plus Tecentriq Doesn’t Improve NSCLC Outcomes
5
